|

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

RECRUITINGSponsored by IRCCS SYNLAB SDN
Actively Recruiting
SponsorIRCCS SYNLAB SDN
Started2023-04-30
Est. completion2023-12-31
Eligibility
Age1 Year – 18 Years

Summary

Long non-coding RNAs (lncRNAs) are a class of biomarkers of crescent interest in the hematologic and oncologic field. They do not encode proteins and can alter gene expression by acting on different steps of regulation, including DNA methylation and chromatin structure. Recent data identified recurrent somatic alterations in genes involved in DNA methylation and post-translational histone modifications in T-ALL, suggesting that epigenetic homeostasis is critically required in restraining tumor development in the T-cell lineage. Further, recent studies showed that the expression levels of specific lncRNAs correlate with the prognosis of patients with Acute Lymphoblastic Leukemia of T-cells (T-ALL). The objectives of this research project are to identify T-ALL-specific lncRNAs to be used as new diagnostic and prognostic biomarkers of disease and to explore their role on chromatin reorganization and transcriptional regulation that may lead to the onset and progression of T-ALL.

Eligibility

Age: 1 Year – 18 Years
Inclusion Criteria:

* Patients with a diagnosis of T-ALL 1-18 years aged of both sexes;
* Presence of leukemic cells in peripheral blood of recruited patients.

Exclusion Criteria:

* Patients who refuse to participate in the study;
* Patients not falling in the age group mentioned above

Conditions2

Acute Lymphoblastic Leukemia, PediatricCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.